ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

In Brief: Wyngaarden Delays Gene Transfer Study, Seeks all Information; Rosenberg Wins Griffuel Prize

October 28, 1988

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013